A prodrug approach to COX-2 inhibitors with methylsulfone.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2004-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2004.01.048PMID 15026065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transdermal and Topical Drug Delivery Systems

  2004cited by this paper
• 2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors.

  2003cited by this paper
• A facile one-pot synthesis of 4,5-diaryl-2,2-dimethyl-3(2H)-furanones.

  2002cited by this paper
• 4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1).

  2002cited by this paper
• Advances in the field of COX-2 inhibition

  2002cited by this paper
• 2,2-Dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors.

  2001cited by this paper
• 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2.

  2000cited by this paper
• N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration.

  2000cited by this paper
• Pyrroles and other heterocycles as inhibitors of p38 kinase.

  1998cited by this paper
• Principles of medicinal chemistry

  1974cited by this paper

• Chemoselective synthesis of 4-[(alkylsulfinyl)methyl]-3,5-dimethylisoxazoles facilitated by 1,1-di(hydroperoxy)cyclohexane

  2023cites this paper
• Interconnection of sulfides and sulfoxides in medicinal chemistry

  2018cites this paper
• Current status of COX-2 inhibitors.

  2008cites this paper
• Quantitative structure-activity relationships for commercially available inhibitors of COX-2.

  2008cites this paper
• Pharmacokinetics and distribution of [35S]methylsulfonylmethane following oral administration to rats.

  2007cites this paper
• Racemic and chiral sulfoxides as potential prodrugs of 4-pyrone COX-2 inhibitors.

  2006cites this paper
• Open-label, randomized, controlled pilot study of the effects of a glucosamine complex on Low back pain.

  2005cites this paper
• COX-2 inhibitors with a methylsulfoxide pharmacophore

  2005cites this paper